166 related articles for article (PubMed ID: 27637482)
21. Further development of the rat Pig-a mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes.
Kimoto T; Chikura S; Suzuki K; Kobayashi Xm; Itano Y; Horibata K; Honma M; Dobrovolsky VN; Heflich RH; Miura D; Kasahara Y
Environ Mol Mutagen; 2011 Dec; 52(9):774-83. PubMed ID: 22167888
[TBL] [Abstract][Full Text] [Related]
22. Analysis of mutation in the rat Pig-a assay: I) studies with bone marrow erythroid cells.
Revollo JR; Pearce MG; Dad A; Petibone DM; Robison TW; Roberts D; Dobrovolsky VN
Environ Mol Mutagen; 2018 Oct; 59(8):722-732. PubMed ID: 30091272
[TBL] [Abstract][Full Text] [Related]
23. Multi-laboratory evaluation of 1,3-propane sultone, N-propyl-N-nitrosourea, and mitomycin C in the Pig-a mutation assay in vivo.
Chung YS; Pak B; Han S; Lee J; Kim J; Back SM; Park CR; Kim SH; Lee JK
Mutat Res Genet Toxicol Environ Mutagen; 2018 Jul; 831():62-68. PubMed ID: 29875078
[TBL] [Abstract][Full Text] [Related]
24. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat.
Miura D; Dobrovolsky VN; Kasahara Y; Katsuura Y; Heflich RH
Environ Mol Mutagen; 2008 Oct; 49(8):614-21. PubMed ID: 18626999
[TBL] [Abstract][Full Text] [Related]
25. International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories.
Dertinger SD; Phonethepswath S; Weller P; Nicolette J; Murray J; Sonders P; Vohr HW; Shi J; Krsmanovic L; Gleason C; Custer L; Henwood A; Sweder K; Stankowski LF; Roberts DJ; Giddings A; Kenny J; Lynch AM; Defrain C; Nesslany F; van der Leede BJ; Van Doninck T; Schuermans A; Tanaka K; Hiwata Y; Tajima O; Wilde E; Elhajouji A; Gunther WC; Thiffeault CJ; Shutsky TJ; Fiedler RD; Kimoto T; Bhalli JA; Heflich RH; MacGregor JT
Environ Mol Mutagen; 2011 Dec; 52(9):690-8. PubMed ID: 21910140
[TBL] [Abstract][Full Text] [Related]
26. In Vivo Pig-a gene mutation assay: Guidance for 3Rs-friendly implementation.
Raschke M; Igl BW; Kenny J; Collins J; Dertinger SD; Labash C; Bhalli JA; Tebbe CC; McNeil KM; Sutter A
Environ Mol Mutagen; 2016 Dec; 57(9):678-686. PubMed ID: 27770464
[TBL] [Abstract][Full Text] [Related]
27. Efficient monitoring of in vivo pig-a gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds.
Dertinger SD; Phonethepswath S; Avlasevich SL; Torous DK; Mereness J; Bryce SM; Bemis JC; Bell S; Weller P; Macgregor JT
Toxicol Sci; 2012 Dec; 130(2):328-48. PubMed ID: 22923490
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte-Based Pig-a Gene Mutation Assay.
Bemis JC; Hall NE; Dertinger SD
Methods Mol Biol; 2019; 2031():29-57. PubMed ID: 31473953
[TBL] [Abstract][Full Text] [Related]
29. Applying the erythrocyte Pig-a assay concept to rat epididymal sperm for germ cell mutagenicity evaluation.
Ji Z; LeBaron MJ
Environ Mol Mutagen; 2017 Aug; 58(7):485-493. PubMed ID: 28714084
[TBL] [Abstract][Full Text] [Related]
30. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.
Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S
Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the in vivo mutagenicity of melamine by the RBC Pig-a assay and PIGRET assay.
Kyoya T; Hori M; Terada M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Nov; 811():43-48. PubMed ID: 27931813
[TBL] [Abstract][Full Text] [Related]
32. Comparison of male versus female responses in the Pig-a mutation assay.
Labash C; Avlasevich SL; Carlson K; Torous DK; Berg A; Bemis JC; MacGregor JT; Dertinger SD
Mutagenesis; 2015 May; 30(3):349-57. PubMed ID: 25833915
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the RBC Pig-a assay and the PIGRET assay using benzo[a]pyrene in rats.
Kikuzuki R; Sato H; Fujiwara A; Takahashi T; Ogiwara Y; Sugiura M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Nov; 811():86-90. PubMed ID: 27931821
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of an in vivo Pig-a gene mutation assay for use in regulatory toxicology studies.
Godin-Ethier J; Leroux F; Wang N; Thébaud S; Merah F; Nelson A
Mutagenesis; 2015 May; 30(3):359-63. PubMed ID: 25680869
[TBL] [Abstract][Full Text] [Related]
35. Report on stage III Pig-a mutation assays using benzo[a]pyrene.
Bhalli JA; Shaddock JG; Pearce MG; Dobrovolsky VN; Cao X; Heflich RH; Vohr HW
Environ Mol Mutagen; 2011 Dec; 52(9):731-7. PubMed ID: 22052432
[TBL] [Abstract][Full Text] [Related]
36. When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis.
Dertinger SD; Bryce SM; Phonethepswath S; Avlasevich SL
Mutat Res; 2011 Apr; 721(2):163-70. PubMed ID: 21277384
[TBL] [Abstract][Full Text] [Related]
37. Evaluation for a mutagenicity of aristolochic acid by Pig-a and PIGRET assays in rats.
Koyama N; Yonezawa Y; Nakamura M; Sanada H
Mutat Res Genet Toxicol Environ Mutagen; 2016 Nov; 811():80-85. PubMed ID: 27931820
[TBL] [Abstract][Full Text] [Related]
38. Effective use of the Pig-a gene mutation assay for mutagenicity screening: measuring CD59-deficient red blood cells in rats treated with genotoxic chemicals.
Kimoto T; Chikura S; Suzuki-Okada K; Kobayashi XM; Itano Y; Miura D; Kasahara Y
J Toxicol Sci; 2012; 37(5):943-55. PubMed ID: 23038003
[TBL] [Abstract][Full Text] [Related]
39. The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup.
Gollapudi BB; Lynch AM; Heflich RH; Dertinger SD; Dobrovolsky VN; Froetschl R; Horibata K; Kenyon MO; Kimoto T; Lovell DP; Stankowski LF; White PA; Witt KL; Tanir JY
Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():23-35. PubMed ID: 25953398
[TBL] [Abstract][Full Text] [Related]
40. Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens.
Phonethepswath S; Franklin D; Torous DK; Bryce SM; Bemis JC; Raja S; Avlasevich S; Weller P; Hyrien O; Palis J; Macgregor JT; Dertinger SD
Toxicol Sci; 2010 Mar; 114(1):59-70. PubMed ID: 19965957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
